Found 0 matching trials
Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
EARLY_PHASE1This feasibility study will assess the clinical potential of a new imaging ...
Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer
PHASE2The goal of this randomized clinical trial is to learn about if carbon ion ...
Location
Shanghai Proton and Heavy Ion Center
18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study
NAThis study aims to investigate the use of 18F-FMISO PET in identifying hypo...
Location
Singapore General Hospital
Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients
NAThe main purpose of this study is to evaluate low oxygen areas called hypox...
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
PHASE1Purpose of Study This exploratory clinical study will investigate FMISO (fl...
Location
Huntsman Cancer Institute
Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer
NARadiotherapy, preferably combined with chemotherapy, is the treatment stand...
Location
German Cancer Research Center
Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer
PHASE2This randomized phase II trial studies how well positron emission tomograph...
Location
Stanford Cancer Institute Palo Alto
Dose Escalation Using Hypoxia-adjusted Radiotherapy
PHASE2DE-HyART is a phase II clinical trial aimed at understanding the effects of...
Location
Rajiv Gandhi Cancer Institute and Research Centre
Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer
NAHead and neck cancer is the sixth most frequent cancer worldwide, excluding...
Location
CHU de Bordeaux - Hôpital Pellegrin
Evaluation of [18F]-FMISO for Non Operated Glioblastoma
PHASE2Hypoxia is recognized to be an independent predictor of clinical outcome in...
Location
CHU de Bordeaux - Hôpital Pellegrin